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Introduction
A thymoma is a neoplasm originating from the thymic
epithelium and is the most common tumor of the ante-
rior mediastinum. Approximately 40% of thymoma
patients have clinically associated parathymic syndromes,
with myasthenia gravis (MG) being the most common.1
The others, including pure red cell aplasia (PRCA),
hypogammaglobulinemia (Good’s syndrome), autoim-
mune disorders and vasculitis, occur in about 5–10%
of thymoma patients.2 PRCA is characterized by nor-
mocytic anemia, reticulocytopenia and severe erythroid
hypoplasia in the bone marrow but normal myeloid
and megakaryocytic cell lineages.3 Although PRCA
occurs in only 5% of thymoma patients, thymoma can
be found in 50% of PRCA patients.1 This indicates
that PRCA is rarer than MG in thymoma patients,
but the relationship between PRCA and thymoma 
is closer. Thymoma, combined with hypogamma-
globulinemia, was first recognized by Dr Robert
Good in 1954. This occurs in approximately 6–11% of
thymoma patients and is characterized by low serum
immunoglobulin levels, few B cells, abnormal CD4+/
CD8+ T-cell ratios, and CD4 T-cell lymphopenia.1,4
Thymoma patients with PRCA or hypogammaglobu-
linemia are rare, while those with both PRCA and
hypogammaglobulinemia are even rarer. We discuss 
a 46-year-old woman with thymoma, who had simul-
taneous PRCA and hypogammaglobulinemia, who
achieved complete PRCA remission after perioperative
steroid administration and extended thymectomy.
Case Report
A pale 46-year-old woman was referred to hematology
for progressive palpitations, dizziness and shortness of
breath for 5 months. The symptoms were exaggerated,
especially during menstruation. She had also suffered
from recurrent canker sores and common colds in the
past years.
Routine chest radiography disclosed a mass over
the left anterior mediastinal area (Figure 1A). Chest
computed tomography (CT) showed the mass to be
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7.0 × 4.5 × 8.4 cm in size (Figure 1B). Ultrasound-
guided percutaneous fine needle biopsy was performed,
and the pathologist confirmed a diagnosis of thymoma.
Even with mild elevation of AChR-Ab (1.37 nmole/L;
normal range < 0.5), neurologists ruled out MG due
to negative clinical symptoms and signs. Blood tests
revealed severe normocytic anemia with a red cell count
of 2.17 × 106/μL, hemoglobin of 5.0 g/dL and retic-
ulocyte count of 0.09%, but normal white blood cell
and platelet counts. Normal serum bilirubin, serum
haptoglobin, and urine hemosiderin levels ruled out
the possibility of hemolysis. Serum levels of vitamin
B12, folic acid, ferritin and total iron binding capacity
were all within normal limits. Thus, bone marrow biopsy
was done, showing severe erythroid hypoplasia with
normal myeloid and megakaryocytic cell lineages. PRCA
was diagnosed (Figure 2).
Positive antinuclear (1:320) and anti-DS-DNA anti-
bodies (55 IU/mL) were detected, but anti-Smith
and anti-cardiolipin IgM antibodies were not found.
All indicated an aberration in immunologic conditions.
In addition, low IgG (675mg/dL; normal range, 751–
1,560), low IgA (41 mg/dL; normal range, 82–453)
and low C3 (59 mg/dL; normal range, 79–152) were
noted. These led to the suspicion of hypogammaglob-
ulinemia. The woman was diagnosed with thymoma
combined with both PRCA and hypogammaglobu-
linemia. Preoperatively, she was treated with intravenous
dexamethasone 5 mg every 12 hours for 14 days, then
with intravenous methylprednisolone 1,000 mg dur-
ing the operation, and then with oral prednisolone
5 mg twice a day for 1 month after operation. Median
sternotomy was done for extended thymectomy. This
showed a yellow-white mass that measured 7.5 ×
5.5 × 3.5 cm over the left lobe of the thymus (Figure
3A). Microscopically, the tumor invaded into but not
through the fibrous capsule and was composed of
spindle cells with foci rich in lymphocytes, compatible
with thymoma WHO type AB, in Masaoka stage I
(Figure 3B).5
The patient’s hematologic readings are illustrated in
Figure 4. Complete remission from PRCA was achieved
and maintained for at least 3 years. Chest CT also
demonstrated no tumor recurrence. Her perioperative
immunologic changes are listed in Table 1. Her white
cell count (1 year after operation) was 4,680 (1/μL),
with lymphocyte percentage of 42%. The lymphocyte
subpopulations were CD3 of 73%, CD4 of 30%, CD8
of 40%, and CD19 of 8%. The patient did not totally
recover from hypogammaglobulinemia. Clinically, she
has had no severe infection postoperatively till now.
But the canker sores have recurred and continue to
bother her.
A B
Figure 1. (A) Chest radiography shows a huge mass lesion over the left anterior mediastinal area. (B) Chest computed tomography
demonstrates a soft tissue mass measuring 7.0 × 4.5 × 8.4 cm with homogeneous enhancement in the left anterior mediastinum.
Figure 2. Bone marrow biopsy: there is severe erythroid hypoplasia
associated with normal myeloid series (Wright’s stain, 1,000×).
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Figure 3. (A) Gross appearance: a yellowish-white mass lesion about 7.5 × 5.5 × 3.5 cm in size located over the left lobe of the thymus.
(B) Microscopic picture shows a tumor in which foci have features of type A thymoma mixed with foci rich in lymphocytes (hematoxylin &
eosin, 400×).
Preoperative Postoperative
Hematological conditions
14 d 14 d 28 d 6 mo 1 yr 3 yr
Red cell count (M/μL) 2.17 3.58 3.56 5.16 4.9 5.13
Hemoglobin (g/dL) 5.0 10.7 10.9 15.5 14.6 15.6
Hematocrit (%) 15.7 32.6 34.5 47.0 45.6 45.7
Reticulocyte count (%) 0.09 2.74 4.69 0.66 – –
PRPI (‰) 0.10 13.23 23.97 6.89 – –
PRPI = peripheral reticulocyte production index (normal range: 5–15‰) = (patient’s hematocrit (%)/45) × reticulocyte count × (1/correction shift factor of 
maturation time).
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Figure 4. Perioperative changes in hematologic condition.
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Discussion
PRCA, either congenital or acquired, is a disease that
selectively disturbs erythropoiesis.6 Acquired PRCA 
is further divided into primary and secondary. Pri-
mary PRCA has no suspicious causative disease or
drug, and sometimes shows autoantibodies to eryth-
roblasts or erythropoietins, or is a disorder of lym-
phocytes relating to erythropoiesis. For example,
there may be an increase in T-cell suppression that
inhibits erythropoiesis.6 Secondary PRCA, however,
has some suspicious causes, such as thymoma, malig-
nant lymphoma, chronic leukemia, systemic lupus
erythematosus (SLE), and Sjögren’s syndrome. Among
them, thymoma is the most common.7,8 Thymoma
might produce suppressor T-cells or serum thymic
factor that inhibits erythroid differentiation, but the
definite inhibitors have not yet been identified.9–11
The inhibitors may decay after extended thymectomy;
its course can be reflected by peripheral reticulocyte
production index (PRPI) increase (Figure 4). From
14 days before to 14 days after surgery, PRPI in our
patient increased 132-fold, from 0.1‰ to 13.2‰.
This implies an inhibitor drop in the circulation and
adequate compensated erythropoiesis in the bone
marrow. Further detection of inhibitors of eryth-
ropoietin or erythroid progenitor in the future is 
recommended.
Thymoma with hypogammaglobulinemia was first
described by Dr Robert Good in 1954, and termed
Good’s syndrome. It becomes obvious in the 4th or 5th
decades of life, and most patients suffer from recur-
rent sinopulmonary, bacterial urinary tract and skin
infections. Serum shows hypogammaglobulinemia, few
B-cells, an abnormal CD4+/CD8+ ratio and CD4
cell lymphopenia.4 In our case, IgG and IgA were low,
even after extended thymectomy (Table 1). Moreover,
B and CD4+ T lymphocytes were few and accounted
for 8% and 30% of total leukocytes, respectively. A
reversed CD4+ over CD8+ T lymphocyte ratio of 0.75
was also noted. Good’s syndrome does not entirely
improve after treatment.
According to Jeunet in 1965, 35% of Good’s 
syndrome patients also had pure red cell anemia.12
There are only a few reports discussing the coexistence
of PRCA and hypogammaglobulinemia in thymomic
patients in the literature.13–16 The definite mechanism
between thymoma, PRCA and hypogammaglobuline-
mia is still obscure.
The relationship between thymoma histologic type
and PRCA is also not clear. Masaoka et al reported
that 17 thymoma patients with PRCA were all of the
spindle type, in contrast to the polygonal cell types in
myasthenic thymomas.17 But Kuo and Shih doubted
the findings because none of their 5 thymoma patients
with PRCA were of the spindle type. This included 
2 with type B1 thymoma, 2 with type B2 thymoma
and 1 with type AB thymoma (new WHO classifica-
tion).18 All 17 patients reported by Masaoka et al
might be type A thymoma according to the histologic
findings of spindle type thymoma. Our case was stage
I type AB thymoma, characterized by foci having fea-
tures of type A thymoma mixed with foci rich in lym-
phocytes. For thymoma patients with PRCA and
hypogammaglobulinemia, typical histologic types
have not yet been reported. In the 17 thymoma
patients reported by Masaoka et al, 3 had hypogam-
maglobulinemia. They were all spindle cell thymomas
(WHO, type A), different from our case. This dis-
crepancy could be due to a lack of consensus in the
histologic classification of thymoma and the low case
number.
Treatments for thymoma patients with PRCA,
hypogammaglobulinemia or both are also diverse. For
thymoma patients, extended thymectomy is the best
choice of treatment if the thymoma is resectable. For
thymoma patients with PRCA, the complete PRCA
remission rate after extended thymectomy is about
30%.17,19,20 But Kuo and Shih doubted the effects of
surgery, because none of their patients improved after
surgery.18 Adjuvant therapy using immunosuppres-
sive agents might be necessary to achieve complete
remission.17,18 One month of perioperative steroids
plus extended thymectomy led to complete remission
in our case. The surgical effects on hypogammaglob-
ulinemia were varied.17 There are no studies on surgical
resection or multimodal treatments in thymoma patients
with hypogammaglobulinemia in the English literature.
Table 1. Perioperative changes in clinical manifestation and profile
Clinical signs/antibody titers/immunoglobulin levels
Oral ulcer Common cold ANA DS-DNA (IU/mL) IgG (mg/dL) IgA (mg/dL) CD4 (%) CD8 (%)
Preoperative Yes Yes 1:320 55 675 41 – –
Postoperative Yes No 1:160 Negative 608 8.99 30 40
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Extended thymectomy plus intravenous immunoglob-
ulin replacement might be a choice for treating thy-
moma and altering hypogammaglobulinemia to reduce
infection.21
Few have discussed the relationships between PRCA,
thymoma and hypogammaglobulinemia. Treatment
modalities are still controversial. Based on our case and
others, it is hypothesized that some kind of inhibitor
in the thymoma or thymus itself might precipitate the
pathogenesis of PRCA.9–11 Even after extended thymec-
tomy, previously released inhibitors still circulate in
the serum and need time to decay and be eliminated.
Before average or range of time to decay, adjuvant
steroid therapy might be necessary. Intravenous immu-
noglobulin replacement therapy is still controversial,
except when there are serious signs of infection. Our
experience suggests that both extended thymectomy
and immunosuppressive therapy may play key roles in
patients with thymoma who have both PRCA and
hypogammaglobulinemia, but further understanding
and improvement in the management of hypogamma-
globulinemia are necessary.
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